Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5905 Target Snapshot

Aldo-keto reductase family 1 member C1 · SINGLE PROTEIN · Homo sapiens

416Compounds
93Assays
9Approved Drugs
400.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q04828. Use UniProt Q04828 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q04828 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aldo-keto reductase family 1 member C1 as ChEMBL target CHEMBL5905, mapped to UniProt Q04828. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aldo-keto reductase family 1 member C1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5905
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q04828
Aldo-keto reductase family 1 member C1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aldo-keto reductase family 1 member C1 is the right protein anchor across sources, using UniProt Q04828 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAldo-keto reductase family 1 member C1
UniProt AccessionQ04828
Component TypeProtein
Sequence Length323 aa

Aldo-keto reductase family 1 member C1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aldo-keto reductase family 1 member C1, mapped to UniProt Q04828. Sequence length is 323 aa.

Mapped IDQ04828
Review nameAldo-keto reductase family 1 member C1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

9
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC50340.0
KI59.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1275703 9.07 Ki 0.85 Preclinical
CHEMBL1275725 8.89 Ki 1.3 Preclinical
CHEMBL1275704 8.89 Ki 1.3 Preclinical
CHEMBL1277648 8.7 Ki 2.0 Preclinical
CHEMBL1277647 8.68 Ki 2.1 Preclinical
CHEMBL1275723 8.59 Ki 2.6 Preclinical
CHEMBL387536 8.4 Ki 4.0 Preclinical
CHEMBL449129 8.23 Ki 5.9 Preclinical
CHEMBL449129 8.22 IC50 6.0 Preclinical
CHEMBL447448 8.05 Ki 9.0 Preclinical
Distribution

pChEMBL Value Distribution

28
5.0
22
5.5
25
6.0
4
6.5
10
7.0
2
7.5
10
8.0
8
8.5
2
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MECLOFENAMIC ACID
CHEMBL509
Approved 1980
MEFENAMIC ACID
CHEMBL686
Approved 1967
MEDROXYPROGESTERONE ACETATE
CHEMBL717
Approved 1959
Assay Landscape

Assay Landscape

93
Total Assays
157
Tested Compounds
2
Assay Types
Binding — 84 assays, 157 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 48 69 5.8
assay format 30 46 5.3
cell-based format 6 42 5.7
ADME — 9 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 1
cell-based format 3 3 5.0
single protein format 3 4 4.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine